药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfadoxine
Sirukumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Sirukumab.
Sulfadoxine
Brodalumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brodalumab.
Sulfadoxine
Peficitinib
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Peficitinib.
Sulfadoxine
Voclosporin
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Voclosporin.
Sulfadoxine
Pirarubicin
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Pirarubicin.
Sulfadoxine
Ravulizumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ravulizumab.
Sulfadoxine
Ixekizumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ixekizumab.
Sulfadoxine
Melengestrol
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Melengestrol.
Sulfadoxine
Tepoxalin
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tepoxalin.
Sulfadoxine
Fluprednisolone
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fluprednisolone.
Sulfadoxine
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Antilymphocyte immunoglobulin (horse).
Sulfadoxine
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Peginterferon beta-1a.
Sulfadoxine
Tixocortol
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Tixocortol.
Sulfadoxine
Vilanterol
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vilanterol.
Sulfadoxine
Dinutuximab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Dinutuximab.
Sulfadoxine
Idelalisib
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Idelalisib.
Sulfadoxine
Blinatumomab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Blinatumomab.
Sulfadoxine
Vedolizumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vedolizumab.
Sulfadoxine
Obinutuzumab
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Obinutuzumab.
Sulfadoxine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Pomalidomide.